PEE CEE COSMA SOPE
|
PEE CEE COSMA SOPE Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.40 | 6.37 | 18.01 | 7.96 | 10.72 |
| CEPS(Rs) | 15.10 | 8.86 | 20.23 | 10.78 | 12.94 |
| DPS(Rs) | 2.00 | 1.00 | 3.00 | 3.00 | 3.00 |
| Book NAV/Share(Rs) | 114.77 | 106.37 | 103.00 | 84.99 | 84.31 |
| Tax Rate(%) | 25.40 | 26.30 | 26.01 | 26.74 | 29.93 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.16 | 3.02 | 8.12 | 4.72 | 6.14 |
| EBIT Margin(%) | 3.38 | 2.97 | 8.12 | 4.14 | 5.53 |
| Pre Tax Margin(%) | 2.68 | 2.47 | 7.83 | 3.89 | 5.32 |
| PAT Margin (%) | 2.00 | 1.82 | 5.79 | 2.85 | 3.73 |
| Cash Profit Margin (%) | 3.21 | 2.53 | 6.51 | 3.86 | 4.50 |
| Performance Ratios | |||||
| ROA(%) | 5.33 | 4.09 | 14.19 | 6.93 | 10.22 |
| ROE(%) | 8.50 | 6.08 | 19.16 | 9.40 | 13.27 |
| ROCE(%) | 10.25 | 7.62 | 23.07 | 11.59 | 17.28 |
| Asset Turnover(x) | 2.67 | 2.25 | 2.45 | 2.43 | 2.74 |
| Sales/Fixed Asset(x) | 4.20 | 3.70 | 3.94 | 3.60 | 3.84 |
| Working Capital/Sales(x) | 20.20 | 38.52 | 18.85 | 9.72 | 9.24 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.24 | 0.27 | 0.25 | 0.28 | 0.26 |
| Receivable days | 1.71 | 1.81 | 1.57 | 1.75 | 2.17 |
| Inventory Days | 39.58 | 45.96 | 45.93 | 51.86 | 54.86 |
| Payable days | 6.07 | 10.63 | 11.57 | 9.91 | 9.15 |
| Valuation Parameters | |||||
| PER(x) | 10.53 | 19.31 | 6.19 | 5.60 | 9.14 |
| PCE(x) | 6.55 | 13.88 | 5.51 | 4.13 | 7.57 |
| Price/Book(x) | 0.86 | 1.16 | 1.08 | 0.52 | 1.16 |
| Yield(%) | 2.02 | 0.81 | 2.69 | 6.73 | 3.06 |
| EV/Net Sales(x) | 0.29 | 0.48 | 0.40 | 0.19 | 0.38 |
| EV/Core EBITDA(x) | 6.29 | 13.03 | 4.49 | 3.74 | 6.01 |
| EV/EBIT(x) | 8.54 | 16.15 | 4.88 | 4.66 | 6.85 |
| EV/CE(x) | 0.78 | 0.95 | 0.92 | 0.45 | 0.99 |
| M Cap / Sales | 0.21 | 0.35 | 0.36 | 0.16 | 0.34 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 34.33 | 12.69 | 11.24 | -2.76 | -0.49 |
| Core EBITDA Growth(%) | 67.56 | -53.04 | 90.74 | -20.55 | -25.93 |
| EBIT Growth(%) | 52.85 | -58.79 | 118.19 | -27.25 | -27.40 |
| PAT Growth(%) | 47.52 | -64.64 | 126.39 | -25.78 | -22.68 |
| EPS Growth(%) | 47.52 | -64.64 | 126.38 | -25.78 | -22.68 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.33 | 0.48 | 0.12 | 0.21 | 0.14 |
| Current Ratio(x) | 1.59 | 1.20 | 1.53 | 1.86 | 2.22 |
| Quick Ratio(x) | 0.15 | 0.23 | 0.15 | 0.81 | 0.48 |
| Interest Cover(x) | 4.81 | 5.90 | 28.00 | 16.28 | 26.31 |
| Total Debt/Mcap(x) | 0.39 | 0.41 | 0.11 | 0.41 | 0.12 |
Compare Financial Ratios of peers of PEE CEE COSMA SOPE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PEE CEE COSMA SOPE | ₹112.3 Cr | 4.8% | 7.1% | 260.1% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹546,844.0 Cr | -0.9% | 5.1% | -13.3% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹132,931.0 Cr | -0.5% | 11.8% | 28% | Stock Analytics | |
| DABUR INDIA | ₹95,672.4 Cr | -2.6% | 7.1% | 1% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹73,188.6 Cr | -4.5% | 0.9% | 61.5% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹50,929.4 Cr | -0.6% | -2% | 13% | Stock Analytics | |
PEE CEE COSMA SOPE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PEE CEE COSMA SOPE | 4.8% |
7.1% |
260.1% |
| SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses
